{
    "clinical_study": {
        "@rank": "107549", 
        "acronym": "FitMeFit", 
        "arm_group": [
            {
                "arm_group_label": "control (C) group", 
                "arm_group_type": "No Intervention", 
                "description": "The control group will remain in routine care for 12 weeks."
            }, 
            {
                "arm_group_label": "telemedical (TM) group", 
                "arm_group_type": "Experimental", 
                "description": "Participants in the telemedical (TM) group will get a weighing machine and a step counter, with automatic transfer into a personalized online portal, which can be monitored from both, the participant and the study centre."
            }, 
            {
                "arm_group_label": "telemedical coaching (TMC) group", 
                "arm_group_type": "Experimental", 
                "description": "Participants in the telemedical coaching (TMC) group will get a weighing machine and a step counter, with automatic transfer into a personalized online portal, which can be monitored from both, the participant and the study centre. Additionally, they will be called once per week for 12 weeks from the study centre aiming to discuss measured data and to fix target agreements."
            }
        ], 
        "brief_summary": {
            "textblock": "Lifestyle changes often fail due to loss of motivation. Telemedicine and personal coaching\n      have the potential to support lifestyle change and weight loss. Therefore, the aim of our\n      randomized controlled trial was to examine the effect of telemedicine with and without\n      coaching in comparison to a control group on weight loss in overweight participants."
        }, 
        "brief_title": "TeleLifestyleCoaching for Weight Loss", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Overweight", 
        "condition_browse": {
            "mesh_term": [
                "Weight Loss", 
                "Overweight"
            ]
        }, 
        "detailed_description": {
            "textblock": "In an occupational health care setting overweight employees were randomized into a three arm\n      12-week trial. Participants in the telemedical (TM) and telemedical coaching (TMC) group got\n      a weighing machine and a step counter, with automatic transfer into a personalized online\n      portal, which could be monitored from both, the participant and the study centre. The TMC\n      group weekly got care calls from the study centre aiming to discuss measured data and to fix\n      target agreements. The control group remained in routine care. Wilcoxon signed rank test was\n      used to determine if differences (baseline vs. after 12 weeks) were significantly different\n      from 0 and ANOVA test for determination of inter group differences."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  BMI \u226527 kg/m2\n\n        Exclusion Criteria:\n\n          -  Hypoglycemia inducing medication\n\n          -  severe disease with hospital stay during the last 3 months\n\n          -  smoking cessation for less then 3 months\n\n          -  planned smoking cessation during study phase\n\n          -  acute infects\n\n          -  chronic diseases"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01868763", 
            "org_study_id": "FitMeFit"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "telemedical (TM) group", 
                    "telemedical coaching (TMC) group"
                ], 
                "intervention_name": "telemedical devices (weighing machine and step counter)", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "telemedical coaching (TMC) group", 
                "intervention_name": "care calls once per week for 12 weeks", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "telemedicine", 
            "coaching", 
            "lifestyle change", 
            "weight loss"
        ], 
        "lastchanged_date": "June 4, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "D\u00fcsseldorf", 
                    "country": "Germany", 
                    "zip": "40591"
                }, 
                "name": "West-German Centre of Diabetes and Health"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "3", 
        "official_title": "TeleLifestyleCoaching Use of Telemedicine for Weight Loss and Care of Weight Associated Illnesses", 
        "overall_official": {
            "affiliation": "West-German Centre of Diabetes and Health", 
            "last_name": "Stephan Martin, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Weight will be measured at baseline and after 12 weeks", 
            "measure": "weight loss", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01868763"
        }, 
        "responsible_party": {
            "investigator_affiliation": "West German Center of Diabetes and Health", 
            "investigator_full_name": "Stephan Martin", 
            "investigator_title": "Director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Body mass index [kg/m2], waist circumference [cm], blood pressure [mmHg], triglycerides [mg/dl], HbA1c [%], total, HDL and LDL cholesterol [mg/dl]", 
            "measure": "cardiometabolic risk factors", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "source": "West German Center of Diabetes and Health", 
        "sponsors": {
            "collaborator": {
                "agency": "HMM Holding AG", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "West German Center of Diabetes and Health", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}